Compounds > 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one
Page last updated: 2024-08-26

2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one and Hepatic Encephalopathy

2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one has been researched along with Hepatic Encephalopathy in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baraldi, M; Penne, A; Pinelli, G; Ricci, P; Santi, M; Ventura, E; Zeneroli, ML1
Basile, AS; Fromm, C; Gu, ZQ; Holt, AG; Nowak, G; Yurdaydin, C1
Baraldi, M1
Ebner, J; Ferenci, P; Rzepczynski, D; Zieve, L; Zimmermann, C1
Bassett, ML; Jones, EA; Martin, JV; Mendelson, WB; Mullen, KD1

Reviews

2 review(s) available for 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one and Hepatic Encephalopathy

ArticleYear
Supersensitivity of GABA-A receptors in hepatic encephalopathy.
    Neurochemical research, 1990, Volume: 15, Issue:2

    Topics: Animals; Dogs; GABA-A Receptor Antagonists; Hepatic Encephalopathy; Pyrazoles; Receptors, GABA-A

1990
Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
    Lancet (London, England), 1988, Feb-27, Volume: 1, Issue:8583

    Topics: Benzodiazepines; Flumazenil; Hepatic Encephalopathy; Humans; Ligands; Pyrazoles; Receptors, GABA-A; Synaptic Transmission

1988

Other Studies

3 other study(ies) available for 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one and Hepatic Encephalopathy

ArticleYear
Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.
    Clinical science (London, England : 1979), 1984, Volume: 67, Issue:2

    Topics: Animals; Benzodiazepines; Brain; Diazepam; Evoked Potentials, Visual; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Kinetics; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A

1984
Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: relationship between brain concentration and severity of encephalopathy.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:2

    Topics: Animals; Azides; Benzodiazepines; Benzodiazepinones; Brain; Disease Models, Animal; GABA-A Receptor Antagonists; Hepatic Encephalopathy; Ligands; Male; Motor Activity; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, GABA-A

1993
A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.
    Metabolic brain disease, 1987, Volume: 2, Issue:3

    Topics: Animals; Benzodiazepines; Brain; Diazepam; gamma-Aminobutyric Acid; Hepatic Artery; Hepatic Encephalopathy; Ischemia; Kinetics; Liver Circulation; Male; Portacaval Shunt, Surgical; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reference Values

1987